Community Academic Profiles–

Donna Peehl, PhD

Back to Profile

Publication Details

  • Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.

    Shibata A, Garcia MI, Cheng I, Stamey TA, McNeal JE, Brooks JD, Henderson S, Yemoto CE, Peehl DM. Prostate. 2002; 52 (4): 269-78

    Cytosine-adenine-guanine repeat length of the androgen receptor gene and the A49T and V89L polymorphisms of the 5 alpha-reductase (SRD5A2) gene have been associated with prostate cancer.

    PubMedID: 12210487

Stanford Medicine Resources:

Footer Links: